Clinical Trial Update: Effect of Pitavastatin on Coronary Flow Reserve in Hypertensive Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of pitavastatin on coronary flow reserve in hypertensive patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Pitavastatin (Pitavastatin)

Snippet

Sponsor: Asan Medical Center | Conditions: Hypertension, Cardiovascular Risk | Phase 4 | Status: COMPLETED